CXCR4 and breast carcinoma: NT21MP inhibited tumor growth and the expression of PDGFRα, and EMT-associated proteins had similar expression patterns to the experimental results observed in vitro, suggesting NT21MP may inhibit tumor resistance by inhibiting the CXCR4/PDGFRα signaling mechanism in breast cancer.